Table 1.
Organism | Relevant Gene(s) Mutation* |
Phenotype | Reference |
---|---|---|---|
C. elegans |
unc-51 (Atg1/ULK); bec-1 (Atg6/beclin 1) |
Decreased worm length** |
(Aladzsity et al., 2007) |
daf-2 (Igf-1) | Increased cell size rescued by unc-51 or bec-1 mutants |
(Aladzsity et al., 2007); (McCulloch and Gems, 2003) |
|
Drosophila |
Atg1 (ULK) overexpression |
Decreased cell size | (Scott et al., 2007) |
Atg1−/− | Normal cell size in well- fed animals; increased size in rapamycin-treated animals |
(Scott et al., 2007) | |
Atg1−/−, dTOR |
Atg1−/− partially rescues the decreased cell size of dTOR mutants |
(Lee et al., 2007) | |
Mammalian | Atg5−/− (mouse cell lines) | Increased cell size of starved fibroblasts; no change in cell cycle profile; no impairment of entry into quiescence |
(Hosokawa et al., 2006); (Valentin and Yang, 2008) |
beclin 1+/− (mice) | Increased proliferation in mammary epithelial cells and splenic germinal center lymphocytes |
(Qu et al., 2003) | |
Ambra1−/− (mice) | Increased cell proliferation in fetal brain |
(Fimia et al., 2007) | |
Atg7 shRNA, Atg5 shRNA (human cell lines) |
Delayed onset of senescence |
(Young et al., 2009) |
Gene names in other organisms listed in parentheses
Decreased cell size in autophagy-deficient C. elegans is proposed to occur through impaired ability to utilize cytosolic materials for cell remodeling and elongated cell shape.